- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The Wall Street Journal reported that some bonders and unsecured creditors for Molycorp (OTCMKTS:MCPIQ) are claiming that Molycorp isn’t doing its best to steer itself out of bankruptcy. The creditors claim that the company “has capitulated to demands from Oaktree Capital Group.”
The Wall Street Journal reported that some bonders and unsecured creditors for Molycorp (OTCMKTS:MCPIQ) are claiming that Molycorp isn’t doing its best to steer itself out of bankruptcy. The creditors claim that the company “has capitulated to demands from Oaktree Capital Group.”
As quoted in the publication:
The company is mothballing its California production facility and is pinning its hopes on its rare-earths processing business, Neo. Bondholders said a “frantic” two-month sale effort is not the best way to get the value out of the business, and they have moved to terminate the period during which only Molycorp can propose a chapter 11 plan.
Oaktree last year reached a deal to provide up to $400 million in rescue financing to Molycorp, a deal that allowed Oaktree to negotiate for a relatively safe position in a restructuring of the company’s debt.
Click here for the full article from the Wall Street Journal.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.